Cyclin D1 overexpression in Spitz nevi: an immunohistochemical study.

The morphologic distinction between Spitz nevus and malignant melanoma can be difficult. Because cyclin D1 has been reported to be overexpressed in malignant melanomas, but not in common acquired nevi, we hypothesized that cyclin D1 might be a useful marker to distinguish Spitz nevi from malignant melanoma. Thus, we assessed for cyclin D1 expression in 11 Spitz nevi (10 compound and 1 intradermal) and 9 malignant melanomas (4 Clark stages I-III and 5 Clark stages IV-V) using an immunohistochemical method and routinely fixed and processed tissues. The cyclin D1 results were arbitrarily divided into three groups: 0% to 10%, >10% to 25%, and >25%. We confirmed the observations reported previously by others that cyclin D1 is expressed in malignant melanomas but not in common acquired nevi. Unexpectedly, a relatively high number of cyclin D1-positive cells (i.e., >10%) was also found in all cases of Spitz nevus. However, unlike malignant melanoma, the cyclin D1 positivity in Spitz nevi was present in a zonal pattern. In other words, the number of cyclin D1-positive cells decreased as the lesion extended more deeply, with the number of positive cells in the reticular dermis being less than that in the papillary dermis. Fluorescence in situ hybridization methods were used to assess amplification of 11q13, the locus harboring the cyclin D1 gene, in four cases of Spitz nevus; all were disomic. Using the antibody MIB-1, we compared cyclin D1 expression to the proliferation rate in Spitz nevi. Despite the high cyclin D1 positivity, all Spitz nevi had a relatively low number of MIB-1-positive cells (mean=3.2%), which was significantly lower than that of malignant melanomas (mean=15.3%) (p < 0.001). Thus, unlike malignant melanoma, there appears to be a dissociation between cyclin D1 overexpression and cell proliferation in Spitz nevi.

[1]  O. Larsson,et al.  Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[2]  Y. Collan,et al.  Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage , 1997, International journal of cancer.

[3]  V. Tron,et al.  Overexpression of the cyclin‐dependent kinase inhibitor p21WAF1/GIP1 in human cutaneous malignant melanoma , 1997, Journal of cutaneous pathology.

[4]  R. Brynes Demonstration of cyclin D1 (bcl-1) in mantle cell lymphoma, enhanced staining using heat and ultrasound epitope retrieval , 1997 .

[5]  J. Bartek,et al.  The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. , 1996, Cancer research.

[6]  G. Peters,et al.  Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.

[7]  S. Inohara,et al.  Expression of cyclin D1 and p53 protein in various malignant skin tumors. , 1996, Dermatology.

[8]  M. Rieber,et al.  Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation. , 1995, Biochemical and biophysical research communications.

[9]  A. Rustgi,et al.  Human cyclin D1 oncogene and esophageal squamous cell carcinoma , 1995, Cancer.

[10]  N. Hayward,et al.  Mutations and defective expression of the WAF1 p21 tumour‐suppressor gene in malignant melanomas , 1995, Melanoma research.

[11]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[12]  T. Hunter,et al.  Cyclins and cancer II: Cyclin D and CDK inhibitors come of age , 1994, Cell.

[13]  M. Slovak,et al.  Detection of the Philadelphia chromosome in paraffin-embedded tissue by fluorescence in situ hybridization. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  Yi-Song Wang,et al.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. , 1994, Cancer research.

[15]  K. Helin,et al.  Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. , 1993, Genes & development.

[16]  J. A. Hamilton,et al.  Expression and amplification of cyclin genes in human breast cancer. , 1993, Oncogene.

[17]  P. Tu,et al.  Proliferative Activities in Spitz Nevus Compared with Melanocytic Nevus and Malignant Melanoma Using Expression of PCNA/Cyclin and Mitotic Rate , 1993, The American Journal of dermatopathology.

[18]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.